News

IPO of QSAM Biosciences: Attempt to Beat Cancer
IPO of QSAM Biosciences: Attempt to Beat Cancer

QSAM Biosciences is engaged in the development of radiopharmaceutical medicines for cancer treatment. The company is planning to go public on 7 April by listing on the NASDAQ. We’re studying the issuer’s financial performance and trying to find out whether the stock might find its audience among investors.

The post IPO of QSAM Biosciences: Attempt to Beat Cancer appeared first at R Blog – RoboForex.